StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Gland Pharma Limited
NSE:GLAND.NS
Sector
Location
Market Cap
USD 3.58 B
Share Price
USD 21.93
Avg Daily Volume
202,426
Change (1 day)
-0.44%
Change (1 year)
-9.84%
Change (YTD)
5.50%
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2025: USD 107.04 M
Gland Pharma Limited Operating Cash Flow is USD 107.04 M for the year ending March 31, 2025, a -10.43% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2024 was USD 119.51 M, a 169.86% change year over year.
-
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2023 was USD 44.28 M, a -57.48% change year over year.
-
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2022 was USD 104.14 M, a 26.06% change year over year.
-
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2021 was USD 82.62 M, a -11.18% change year over year.
Competitors
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Cencora, Inc.
USD 300.16
COR
+2.13
0.71%
Regeneron Pharmaceuticals, Inc.
USD 552.58
REGN
+4.83
0.88%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.96
600276.SS
+0.52
7.00%
Takeda Pharmaceutical Company Limited
USD 30.27
4502.T
+0.31
1.03%
Haleon plc
USD 4.99
HLN.L
-0.05
-1.05%
Daiichi Sankyo Company, Limited
USD 22.02
4568.T
+0.64
2.97%
Ucb S.A.
USD 199.58
UCB.BR
+0.15
0.08%
BeOne Medicines Ltd.
USD 255.69
ONC
+11.22
4.59%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Cencora, Inc.
USD 300.16
COR
+2.13
0.71%
Regeneron Pharmaceuticals, Inc.
USD 552.58
REGN
+4.83
0.88%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.96
600276.SS
+0.52
7.00%
Takeda Pharmaceutical Company Limited
USD 30.27
4502.T
+0.31
1.03%
Haleon plc
USD 4.99
HLN.L
-0.05
-1.05%
Daiichi Sankyo Company, Limited
USD 22.02
4568.T
+0.64
2.97%
Ucb S.A.
USD 199.58
UCB.BR
+0.15
0.08%
BeOne Medicines Ltd.
USD 255.69
ONC
+11.22
4.59%